Forbes: This startup wants to make fitness accessible for all
UC alumnus Ryan Eder's inclusive health and wellness platform continues to gain traction
Startups pivot. It happens all the time. Plenty of companies have canned their original ideas in order to go in a different direction entirely.
But for Ohio-based IncludeHealth, its shift has only deepened its commitment to its original mission — accessible fitness for all — even though it’s found a totally new home in software and data analytics instead.
For founder and CEO Ryan Eder, it’s also a show of persistence — IncludeHealth has been a nearly 14-year journey that started during his senior year of college at the University of Cincinnati. Now, the company is working with Cincinnati Children’s Hospital Medical Center in a partnership that could take musculoskeletal care to the next level.
And that’s only the most recent bit of news.
“For me, my primary driver through all this has been to help people,” the alumnus told Forbes. “If you’re not solving a problem and helping others, what’s the point?”
Related Stories
Recent advances may speed time to endometriosis diagnosis
March 16, 2026
The average time to clinical diagnosis of endometriosis is nine years. Definitive diagnosis of the disease is difficult, and until recently, has relied on laparoscopic surgery. Now, as Medscape recently reported, novel clinical recommendations, advanced diagnostic tools and research into inflammation and immune responses, are bringing promise that women with endometriosis will find relief sooner and without surgery, according to experts, including Katie Burns, PhD, University of Cincinnati College of Medicine associate professor.
Local media highlight completion of Blood Cancer Healing Center fourth and fifth floors
March 16, 2026
Local media including WLWT and the Cincinnati Business Courier highlighted the opening of research laboratories and the UC Osher Wellness Suite and Learning Kitchen at the University of Cincinnati Cancer Center’s Blood Cancer Healing Center.
Trial results support weekly buprenorphine treatment of opioid use disorder during pregnancy
March 16, 2026
Supported by the National Institutes of Health (NIH), researchers led by the University of Cincinnati's John Winhusen published clinical trial results in JAMA Internal Medicine that found administering weekly injectable extended-release buprenorphine for treatment of opioid use disorder during pregnancy led to higher rates of abstinence from illicit opioids than buprenorphine given daily under the tongue, one of the standard methods of treatment.